Systematic review / meta-analysis / 2017
Pomegranate supplementation did not significantly alter glucose or insulin measures in trials
A meta-analysis of 16 randomized controlled trials with 538 adult participants evaluated pomegranate supplementation. Pomegranate intake did not significantly alter fasting blood glucose (WMD -0.6 mg/dL, 95% CI: -2.79 to 1.58), fasting blood insulin (WMD 0.29 μIU/mL, 95% CI: -1.16 to 1.75), HOMA-IR, or HbA1c (WMD -0.11%, 95% CI: -0.39 to -0.18). The authors concluded pomegranate is not recommended for glycemic management.
- Study type
- Meta-analysis of randomized controlled trials
- Who was studied
- 538 adults across 16 randomized controlled trials
- What was measured
- Fasting blood glucose, fasting insulin, HbA1c, and HOMA-IR
THE PAPER
Lack of efficacy of pomegranate supplementation for glucose management, insulin levels and sensitivity: evidence from a systematic review and meta-analysis.
Huang H, Liao D, Chen G, Chen H, Zhu Y. Nutr J, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.